Correlation Between 23Andme Holding and Biora Therapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Biora Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Biora Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Biora Therapeutics, you can compare the effects of market volatilities on 23Andme Holding and Biora Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Biora Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Biora Therapeutics.
Diversification Opportunities for 23Andme Holding and Biora Therapeutics
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between 23Andme and Biora is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Biora Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biora Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Biora Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biora Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Biora Therapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and Biora Therapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Biora Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, 23Andme Holding Co is 1.74 times less risky than Biora Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Biora Therapeutics is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 4,500 in Biora Therapeutics on August 30, 2024 and sell it today you would lose (4,307) from holding Biora Therapeutics or give up 95.71% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 99.8% |
Values | Daily Returns |
23Andme Holding Co vs. Biora Therapeutics
Performance |
Timeline |
23Andme Holding |
Biora Therapeutics |
23Andme Holding and Biora Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 23Andme Holding and Biora Therapeutics
The main advantage of trading using opposite 23Andme Holding and Biora Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Biora Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biora Therapeutics will offset losses from the drop in Biora Therapeutics' long position.23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
Biora Therapeutics vs. Enveric Biosciences | Biora Therapeutics vs. Elevation Oncology | Biora Therapeutics vs. Hepion Pharmaceuticals | Biora Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |